Who makes [18F]F-FAPI PET-CT?

[18F]F-FAPI PET-CT is developed by Mara Veenstra, MD.

What development phase is [18F]F-FAPI PET-CT in?

[18F]F-FAPI PET-CT is in Phase 2.

Last reviewed 2026-04-19 · How we verify

[18F]F-FAPI PET-CT

Mara Veenstra, MD · Phase 2 active Small molecule

At a glance

Generic name	[18F]F-FAPI PET-CT
Sponsor	Mara Veenstra, MD
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[18F]F-FAPI PET-CT CI brief — competitive landscape report
[18F]F-FAPI PET-CT updates RSS · CI watch RSS
Mara Veenstra, MD portfolio CI